trigonella foenum-graecum
Botanicalexperimental
Fenugreek is an annual plant in the family Fabaceae, with leaves consisting of three small obovate to oblong leaflets. It is cultivated worldwide as a semiarid crop. Its leaves and seeds are common ingredients in dishes from the Indian subcontinent, and have been used as a culinary ingredient since ancient times. Its use as a food ingredient in small quantities is safe. — Wikipedia
Clinical trial activity
8 trials · 6 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
5
Phase 3
3
Phase 4
0
Earliest trial started Nov 1, 2014 (NCT02303314)
Timeline
Indications
Mechanism of action
- Unspecified targetUnclear
unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaFenugreek ↗
Also known as
- trigonella foenum-graecum
- trigonella foenum-graecum seed extract
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05795816 | Phase 3 | Oct 25, 2023 | RDC Clinical Pty Ltd |
| NCT05232279 | Phase 3 | Apr 20, 2022 | RDC Clinical Pty Ltd |
| NCT05267925 | N/A | Jan 8, 2022 | National College of Natural Medicine |
| NCT05631431 | Phase 2 | Oct 15, 2021 | CuraLife |
| NCT05439473 | Phase 2 | Aug 3, 2021 | CuraLife |
| NCT04949932 | N/A | Apr 3, 2021 | Hamdard University |
| NCT04123743 | Phase 1/Phase 2 (Phase 2) | Aug 10, 2019 | University of Indonesia |
| NCT02303314 | Phase 2/Phase 3 (Phase 3) | Nov 1, 2014 | University of Tehran |
Showing 8 of 8 trials
Page 1 / 1
Organizations
Research & Development (6)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| CuraLife | For profit | 2 | 2 | 1 | 2021 |
| RDC Clinical Pty Ltd | For profit | 2 | 2 | 1 | 2022 |
| Hamdard University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| National College of Natural Medicine | Academic/Hospital | 1 | 1 | 1 | 2022 |
| University of Indonesia | Academic/Hospital | 1 | 1 | 1 | 2019 |
| University of Tehran | Academic/Hospital | 1 | 1 | 1 | 2014 |
6 organizations
Page 1 / 1